Login / Signup

Castration-resistant prostate cancer diagnosed during leuprorelin treatment for spinal and bulbar muscular atrophy.

Atsuhi YanaseToru SugiharaTakahiro AkimotoHirotaka YokoyamaJun KameiAkira FujisakiSatoshi AndoTameto NaoiMitsuya MoritaTetsuya Fujimura
Published in: IJU case reports (2022)
Prostate cancer can occur even when leuprorelin is used for spinal and bulbar muscular atrophy; therefore, checking serum prostate-specific antigen to screen for prostate cancer before leuprorelin administration should be considered.
Keyphrases
  • prostate cancer
  • radical prostatectomy
  • spinal cord
  • resistance training
  • high throughput
  • spinal cord injury
  • replacement therapy